Heartbeam CEO Eno Transitions to Consulting Role as Part of Reorganization

Dow Jones
06/25

HeartBeam said Chief Executive Robert Eno will transition to a consulting role in a reorganization that will involve licensing its ECG signal technology out for heart attack detection.

The medical technology company said its reorganization will be led by its President Branislav Vajdic and Board Chairman Rich Ferrari.

Vajdic said that in addition to expanding its ECG technology, the company will continue to focus on previously announced clinical studies to accelerate the development of their heart attack detection platform.

HeartBeam said artificial intelligence accelerated the development of its ECG platform and a central focus of its new strategy would be to expand its platform beyond arrhythmia assessment to reliable heart attack detection.

It added that it intends to achieve global adoption by partnering with governments, health systems, and various manufacturers.

Write to Grace Yoon at grace.yoon@wsj.com

(END) Dow Jones Newswires

June 24, 2026 17:23 ET (21:23 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10